{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:06:23Z","timestamp":1774613183419,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":66,"publisher":"Springer US","isbn-type":[{"value":"9781071639252","type":"print"},{"value":"9781071639269","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3926-9_1","type":"book-chapter","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T17:02:12Z","timestamp":1721667732000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An Introduction to Rift Valley Fever Virus"],"prefix":"10.1007","author":[{"given":"Friedemann","family":"Weber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mich\u00e8le","family":"Bouloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Yves","family":"Lozach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/path.1700340418","volume":"34","author":"R Daubney","year":"1931","unstructured":"Daubney R, Hudson JR, Garnham PC (1931) Enzootic hepatitis or Rift Valley fever. an undescribed virus disease of sheep cattle and man from East Africa. J Pathol Bacteriol 34:545\u2013579","journal-title":"J Pathol Bacteriol"},{"issue":"8","key":"1_CR2","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1099\/jgv.0.001296","volume":"100","author":"D Wright","year":"2019","unstructured":"Wright D, Kortekaas J, Bowden TA, Warimwe GM (2019) Rift Valley fever: biology and epidemiology. J Gen Virol 100(8):1187\u20131199. https:\/\/doi.org\/10.1099\/jgv.0.001296","journal-title":"J Gen Virol"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"1258172","DOI":"10.3389\/fvets.2023.1258172","volume":"10","author":"Y Xu","year":"2023","unstructured":"Xu Y, Wang X, Jiang L, Zhou Y, Liu Y, Wang F, Zhang L (2023) Natural hosts and animal models for Rift Valley fever phlebovirus. Front Vet Sci 10:1258172. https:\/\/doi.org\/10.3389\/fvets.2023.1258172","journal-title":"Front Vet Sci"},{"issue":"1","key":"1_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev-virology-091919-065806","volume":"9","author":"KA Connors","year":"2022","unstructured":"Connors KA, Hartman AL (2022) Advances in understanding neuropathogenesis of Rift Valley fever virus. Annu Rev Virol 9(1):437\u2013450. https:\/\/doi.org\/10.1146\/annurev-virology-091919-065806","journal-title":"Annu Rev Virol"},{"issue":"5","key":"1_CR5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1099\/jgv.0.000765","volume":"98","author":"S Lumley","year":"2017","unstructured":"Lumley S, Horton DL, Hernandez-Triana LLM, Johnson N, Fooks AR, Hewson R (2017) Rift Valley fever virus: strategies for maintenance, survival and vertical transmission in mosquitoes. J Gen Virol 98(5):875\u2013887. https:\/\/doi.org\/10.1099\/jgv.0.000765","journal-title":"J Gen Virol"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.antiviral.2016.07.005","volume":"132","author":"BH Bird","year":"2016","unstructured":"Bird BH, McElroy AK (2016) Rift Valley fever virus: unanswered questions. Antivir Res 132:274\u2013280. https:\/\/doi.org\/10.1016\/j.antiviral.2016.07.005","journal-title":"Antivir Res"},{"issue":"1","key":"1_CR7","doi-asserted-by":"publisher","first-page":"9822","DOI":"10.1038\/s41598-021-89226-z","volume":"11","author":"KM Gregor","year":"2021","unstructured":"Gregor KM, Michaely LM, Gutjahr B, Rissmann M, Keller M, Dornbusch S, Naccache F, Schon K, Jansen S, Heitmann A, Konig R, Brennan B, Elliott RM, Becker S, Eiden M, Spitzbarth I, Baumgartner W, Puff C, Ulrich R, Groschup MH (2021) Rift Valley fever virus detection in susceptible hosts with special emphasis in insects. Sci Rep 11(1):9822. https:\/\/doi.org\/10.1038\/s41598-021-89226-z","journal-title":"Sci Rep"},{"issue":"5","key":"1_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/zph.12153","volume":"62","author":"M Peyre","year":"2015","unstructured":"Peyre M, Chevalier V, Abdo-Salem S, Velthuis A, Antoine-Moussiaux N, Thiry E, Roger F (2015) A systematic scoping study of the socio-economic impact of Rift Valley fever: research gaps and needs. Zoonoses Public Health 62(5):309\u2013325. https:\/\/doi.org\/10.1111\/zph.12153","journal-title":"Zoonoses Public Health"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-ento-010715-023819","volume":"61","author":"KJ Linthicum","year":"2016","unstructured":"Linthicum KJ, Britch SC, Anyamba A (2016) Rift Valley fever: an emerging mosquito-borne disease. Annu Rev Entomol 61:395\u2013415. https:\/\/doi.org\/10.1146\/annurev-ento-010715-023819","journal-title":"Annu Rev Entomol"},{"key":"1_CR10","doi-asserted-by":"publisher","unstructured":"Herath V, Romay G, Urrutia CD, Verchot J (2020) Family level phylogenies reveal relationships of plant viruses within the order Bunyavirales. Viruses 12(9). https:\/\/doi.org\/10.3390\/v12091010","DOI":"10.3390\/v12091010"},{"issue":"21","key":"1_CR11","doi-asserted-by":"publisher","first-page":"10341","DOI":"10.1128\/JVI.01191-08","volume":"82","author":"AN Freiberg","year":"2008","unstructured":"Freiberg AN, Sherman MB, Morais MC, Holbrook MR, Watowich SJ (2008) Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography. J Virol 82(21):10341\u201310348. https:\/\/doi.org\/10.1128\/JVI.01191-08","journal-title":"J Virol"},{"issue":"7","key":"1_CR12","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2217\/fvl.15.52","volume":"10","author":"P L\u00e9ger","year":"2015","unstructured":"L\u00e9ger P, Lozach P-Y (2015) Bunyaviruses: from transmission by arthropods to virus entry into the mammalian host first-target cells. Future Virol 10(7):859\u2013881. https:\/\/doi.org\/10.2217\/fvl.15.52","journal-title":"Future Virol"},{"key":"1_CR13","doi-asserted-by":"publisher","unstructured":"Wuerth JD, Weber F (2016) Phleboviruses and the type I interferon response. Viruses 8(6). https:\/\/doi.org\/10.3390\/v8060174","DOI":"10.3390\/v8060174"},{"issue":"1","key":"1_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011060","volume":"19","author":"H Malet","year":"2023","unstructured":"Malet H, Williams HM, Cusack S, Rosenthal M (2023) The mechanism of genome replication and transcription in bunyaviruses. PLoS Pathog 19(1):e1011060. https:\/\/doi.org\/10.1371\/journal.ppat.1011060","journal-title":"PLoS Pathog"},{"key":"1_CR15","doi-asserted-by":"publisher","unstructured":"Peinado RDS, Eberle RJ, Arni RK, Coronado MA (2022) A review of omics studies on arboviruses: alphavirus, orthobunyavirus and phlebovirus. Viruses 14(10). https:\/\/doi.org\/10.3390\/v14102194","DOI":"10.3390\/v14102194"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/bs.aivir.2023.09.001","volume":"117","author":"SS Ganaie","year":"2023","unstructured":"Ganaie SS, Leung DW, Hartman AL, Amarasinghe GK (2023) Host entry factors of Rift Valley fever virus infection. Adv Virus Res 117:121\u2013136. https:\/\/doi.org\/10.1016\/bs.aivir.2023.09.001","journal-title":"Adv Virus Res"},{"key":"1_CR17","doi-asserted-by":"publisher","unstructured":"Balaraman V, Indran SV, Li Y, Meekins DA, Jakkula L, Liu H, Hays MP, Souza-Neto JA, Gaudreault NN, Hardwidge PR, Wilson WC, Weber F, Richt JA (2023) Identification of host factors for Rift Valley fever Phlebovirus. Viruses 15(11). https:\/\/doi.org\/10.3390\/v15112251","DOI":"10.3390\/v15112251"},{"issue":"11","key":"1_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015483","volume":"5","author":"CM Filone","year":"2010","unstructured":"Filone CM, Hanna SL, Caino MC, Bambina S, Doms RW, Cherry S (2010) Rift Valley fever virus infection of human cells and insect hosts is promoted by protein kinase C epsilon. PLoS One 5(11):e15483. https:\/\/doi.org\/10.1371\/journal.pone.0015483","journal-title":"PLoS One"},{"issue":"24","key":"1_CR19","doi-asserted-by":"publisher","first-page":"13767","DOI":"10.1128\/JVI.01364-12","volume":"86","author":"SM de Boer","year":"2012","unstructured":"de Boer SM, Kortekaas J, de Haan CA, Rottier PJ, Moormann RJ, Bosch BJ (2012) Heparan sulfate facilitates Rift Valley fever virus entry into the cell. J Virol 86(24):13767\u201313771. https:\/\/doi.org\/10.1128\/JVI.01364-12","journal-title":"J Virol"},{"issue":"3","key":"1_CR20","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1128\/JVI.02055-15","volume":"90","author":"AM Riblett","year":"2016","unstructured":"Riblett AM, Blomen VA, Jae LT, Altamura LA, Doms RW, Brummelkamp TR, Wojcechowskyj JA (2016) A haploid genetic screen identifies Heparan sulfate proteoglycans supporting Rift Valley fever virus infection. J Virol 90(3):1414\u20131423. https:\/\/doi.org\/10.1128\/JVI.02055-15","journal-title":"J Virol"},{"issue":"6","key":"1_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/tra.12393","volume":"17","author":"P Leger","year":"2016","unstructured":"Leger P, Tetard M, Youness B, Cordes N, Rouxel RN, Flamand M, Lozach PY (2016) Differential use of the C-type lectins L-SIGN and DC-SIGN for Phlebovirus endocytosis. Traffic 17(6):639\u2013656. https:\/\/doi.org\/10.1111\/tra.12393","journal-title":"Traffic"},{"issue":"1","key":"1_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.chom.2011.06.007","volume":"10","author":"PY Lozach","year":"2011","unstructured":"Lozach PY, Kuhbacher A, Meier R, Mancini R, Bitto D, Bouloy M, Helenius A (2011) DC-SIGN as a receptor for phleboviruses. Cell Host Microbe 10(1):75\u201388. https:\/\/doi.org\/10.1016\/j.chom.2011.06.007","journal-title":"Cell Host Microbe"},{"key":"1_CR23","doi-asserted-by":"publisher","unstructured":"Ganaie SS, Schwarz MM, McMillen CM, Price DA, Feng AX, Albe JR, Wang W, Miersch S, Orvedahl A, Cole AR, Sentmanat MF, Mishra N, Boyles DA, Koenig ZT, Kujawa MR, Demers MA, Hoehl RM, Moyle AB, Wagner ND, Stubbs SH, Cardarelli L, Teyra J, McElroy A, Gross ML, Whelan SPJ, Doench J, Cui X, Brett TJ, Sidhu SS, Virgin HW, Egawa T, Leung DW, Amarasinghe GK, Hartman AL (2021) Lrp1 is a host entry factor for Rift Valley fever virus. Cell 184 (20):5163\u20135178 e5124. https:\/\/doi.org\/10.1016\/j.cell.2021.09.001","DOI":"10.1016\/j.cell.2021.09.001"},{"issue":"7","key":"1_CR24","doi-asserted-by":"publisher","first-page":"e202302005","DOI":"10.26508\/lsa.202302005","volume":"6","author":"S Devignot","year":"2023","unstructured":"Devignot S, Sha TW, Burkard TR, Schmerer P, Hagelkruys A, Mirazimi A, Elling U, Penninger JM, Weber F (2023) Low-density lipoprotein receptor-related protein 1 (LRP1) as an auxiliary host factor for RNA viruses. Life Sci Alliance 6(7):e202302005. https:\/\/doi.org\/10.26508\/lsa.202302005","journal-title":"Life Sci Alliance"},{"issue":"28","key":"1_CR25","doi-asserted-by":"publisher","first-page":"eadh2264","DOI":"10.1126\/sciadv.adh2264","volume":"9","author":"MM Schwarz","year":"2023","unstructured":"Schwarz MM, Ganaie SS, Feng A, Brown G, Yangdon T, White JM, Hoehl RM, McMillen CM, Rush RE, Connors KA, Cui X, Leung DW, Egawa T, Amarasinghe GK, Hartman AL (2023) Lrp1 is essential for lethal Rift Valley fever hepatic disease in mice. Sci Adv 9(28):eadh2264. https:\/\/doi.org\/10.1126\/sciadv.adh2264","journal-title":"Sci Adv"},{"issue":"6","key":"1_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00415-23","volume":"97","author":"E Bermudez-Mendez","year":"2023","unstructured":"Bermudez-Mendez E, Angelino P, van Keulen L, van de Water S, Rockx B, Pijlman GP, Ciuffi A, Kortekaas J, Wichgers Schreur PJ (2023) Transcriptomic profiling reveals intense host-pathogen dispute compromising homeostasis during acute Rift Valley fever virus infection. J Virol 97(6):e0041523. https:\/\/doi.org\/10.1128\/jvi.00415-23","journal-title":"J Virol"},{"key":"1_CR27","doi-asserted-by":"publisher","unstructured":"Koch J, Xin Q, Tischler ND, Lozach PY (2021) Entry of phenuiviruses into mammalian host cells. Viruses 13(2). https:\/\/doi.org\/10.3390\/v13020299","DOI":"10.3390\/v13020299"},{"key":"1_CR28","doi-asserted-by":"publisher","unstructured":"Confort MP, Duboeuf M, Thiesson A, Pons L, Marziali F, Desloire S, Ratinier M, Cimarelli A, Arnaud F (2023) IFITMs from naturally infected animal species exhibit distinct restriction capacities against Toscana and Rift Valley fever viruses. Viruses 15(2). https:\/\/doi.org\/10.3390\/v15020306","DOI":"10.3390\/v15020306"},{"issue":"24","key":"1_CR29","doi-asserted-by":"publisher","first-page":"13642","DOI":"10.1128\/JVI.01973-12","volume":"86","author":"SM de Boer","year":"2012","unstructured":"de Boer SM, Kortekaas J, Spel L, Rottier PJ, Moormann RJ, Bosch BJ (2012) Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein. J Virol 86(24):13642\u201313652. https:\/\/doi.org\/10.1128\/JVI.01973-12","journal-title":"J Virol"},{"issue":"8","key":"1_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011562","volume":"19","author":"J Koch","year":"2023","unstructured":"Koch J, Xin Q, Obr M, Schafer A, Rolfs N, Anagho HA, Kudulyte A, Woltereck L, Kummer S, Campos J, Uckeley ZM, Bell-Sakyi L, Krausslich HG, Schur FK, Acuna C, Lozach PY (2023) The phenuivirus Toscana virus makes an atypical use of vacuolar acidity to enter host cells. PLoS Pathog 19(8):e1011562. https:\/\/doi.org\/10.1371\/journal.ppat.1011562","journal-title":"PLoS Pathog"},{"issue":"36","key":"1_CR31","doi-asserted-by":"publisher","first-page":"E7564","DOI":"10.1073\/pnas.1705176114","volume":"114","author":"Y Wu","year":"2017","unstructured":"Wu Y, Zhu Y, Gao F, Jiao Y, Oladejo BO, Chai Y, Bi Y, Lu S, Dong M, Zhang C, Huang G, Wong G, Li N, Zhang Y, Li Y, Feng WH, Shi Y, Liang M, Zhang R, Qi J, Gao GF (2017) Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope. Proc Natl Acad Sci USA 114(36):E7564\u2013E7573. https:\/\/doi.org\/10.1073\/pnas.1705176114","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1_CR32","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1073\/pnas.1217780110","volume":"110","author":"M Dessau","year":"2013","unstructured":"Dessau M, Modis Y (2013) Crystal structure of glycoprotein C from Rift Valley fever virus. Proc Natl Acad Sci USA 110(5):1696\u20131701. https:\/\/doi.org\/10.1073\/pnas.1217780110","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6363","key":"1_CR33","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1126\/science.aal2712","volume":"358","author":"P Guardado-Calvo","year":"2017","unstructured":"Guardado-Calvo P, Atkovska K, Jeffers SA, Grau N, Backovic M, Perez-Vargas J, de Boer SM, Tortorici MA, Pehau-Arnaudet G, Lepault J, England P, Rottier PJ, Bosch BJ, Hub JS, Rey FA (2017) A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion. Science 358(6363):663\u2013667. https:\/\/doi.org\/10.1126\/science.aal2712","journal-title":"Science"},{"issue":"3","key":"1_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01713-21","volume":"96","author":"X Wang","year":"2022","unstructured":"Wang X, Hu C, Ye W, Wang J, Dong X, Xu J, Li X, Zhang M, Lu H, Zhang F, Wu W, Dai S, Wang HW, Chen Z (2022) Structure of Rift Valley fever virus RNA-dependent RNA polymerase. J Virol 96(3):e0171321. https:\/\/doi.org\/10.1128\/JVI.01713-21","journal-title":"J Virol"},{"issue":"16","key":"1_CR35","doi-asserted-by":"publisher","first-page":"8274","DOI":"10.1128\/JVI.00476-06","volume":"80","author":"S Won","year":"2006","unstructured":"Won S, Ikegami T, Peters CJ, Makino S (2006) NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. J Virol 80(16):8274\u20138278. https:\/\/doi.org\/10.1128\/JVI.00476-06","journal-title":"J Virol"},{"issue":"10","key":"1_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2014.71","volume":"3","author":"F Kreher","year":"2014","unstructured":"Kreher F, Tamietti C, Gommet C, Guillemot L, Ermonval M, Failloux AB, Panthier JJ, Bouloy M, Flamand M (2014) The Rift Valley fever accessory proteins NSm and P78\/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts. Emerg Microbes Infect 3(10):e71. https:\/\/doi.org\/10.1038\/emi.2014.71","journal-title":"Emerg Microbes Infect"},{"key":"1_CR37","doi-asserted-by":"publisher","unstructured":"Hornak KE, Lanchy JM, Lodmell JS (2016) RNA encapsidation and packaging in the phleboviruses. Viruses 8(7). https:\/\/doi.org\/10.3390\/v8070194","DOI":"10.3390\/v8070194"},{"issue":"5","key":"1_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002030","volume":"7","author":"F Ferron","year":"2011","unstructured":"Ferron F, Li Z, Danek EI, Luo D, Wong Y, Coutard B, Lantez V, Charrel R, Canard B, Walz T, Lescar J (2011) The hexamer structure of Rift Valley fever virus nucleoprotein suggests a mechanism for its assembly into ribonucleoprotein complexes. PLoS Pathog 7(5):e1002030. https:\/\/doi.org\/10.1371\/journal.ppat.1002030","journal-title":"PLoS Pathog"},{"issue":"12","key":"1_CR39","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1074\/mcp.RA119.001631","volume":"18","author":"ZM Uckeley","year":"2019","unstructured":"Uckeley ZM, Moeller R, Kuhn LI, Nilsson E, Robens C, Lasswitz L, Lindqvist R, Lenman A, Passos V, Voss Y, Sommerauer C, Kampmann M, Goffinet C, Meissner F, Overby AK, Lozach PY, Gerold G (2019) Quantitative proteomics of Uukuniemi virus-host cell interactions reveals GBF1 as Proviral host factor for phleboviruses. Mol Cell Proteomics 18(12):2401\u20132417. https:\/\/doi.org\/10.1074\/mcp.RA119.001631","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"1_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13071-019-3433-8","volume":"12","author":"WS Lee","year":"2019","unstructured":"Lee WS, Webster JA, Madzokere ET, Stephenson EB, Herrero LJ (2019) Mosquito antiviral defense mechanisms: a delicate balance between innate immunity and persistent viral infection. Parasit Vectors 12(1):165. https:\/\/doi.org\/10.1186\/s13071-019-3433-8","journal-title":"Parasit Vectors"},{"key":"1_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.630438","volume":"12","author":"P Gabrieli","year":"2021","unstructured":"Gabrieli P, Caccia S, Varotto-Boccazzi I, Arnoldi I, Barbieri G, Comandatore F, Epis S (2021) Mosquito trilogy: microbiota, immunity and pathogens, and their implications for the control of disease transmission. Front Microbiol 12:630438. https:\/\/doi.org\/10.3389\/fmicb.2021.630438","journal-title":"Front Microbiol"},{"issue":"3","key":"1_CR42","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1128\/JVI.02795-12","volume":"87","author":"P Leger","year":"2013","unstructured":"Leger P, Lara E, Jagla B, Sismeiro O, Mansuroglu Z, Coppee JY, Bonnefoy E, Bouloy M (2013) Dicer-2- and Piwi-mediated RNA interference in Rift Valley fever virus-infected mosquito cells. J Virol 87(3):1631\u20131648. https:\/\/doi.org\/10.1128\/JVI.02795-12","journal-title":"J Virol"},{"key":"1_CR43","doi-asserted-by":"publisher","unstructured":"Nair N, Osterhaus A, Rimmelzwaan GF, Prajeeth CK (2023) Rift Valley fever virus-infection, pathogenesis and host immune responses. Pathogens 12(9). https:\/\/doi.org\/10.3390\/pathogens12091174","DOI":"10.3390\/pathogens12091174"},{"issue":"1","key":"1_CR44","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.1038\/s41467-023-41171-3","volume":"14","author":"NS Chapman","year":"2023","unstructured":"Chapman NS, Hulswit RJG, Westover JLB, Stass R, Paesen GC, Binshtein E, Reidy JX, Engdahl TB, Handal LS, Flores A, Gowen BB, Bowden TA, Crowe JE Jr (2023) Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses. Nat Commun 14(1):5650. https:\/\/doi.org\/10.1038\/s41467-023-41171-3","journal-title":"Nat Commun"},{"issue":"1","key":"1_CR45","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1038\/s41467-023-40187-z","volume":"14","author":"CM McMillen","year":"2023","unstructured":"McMillen CM, Chapman NS, Hoehl RM, Skvarca LB, Schwarz MM, Handal LS, Crowe JE Jr, Hartman AL (2023) A highly potent human neutralizing antibody prevents vertical transmission of Rift Valley fever virus in a rat model. Nat Commun 14(1):4507. https:\/\/doi.org\/10.1038\/s41467-023-40187-z","journal-title":"Nat Commun"},{"key":"1_CR46","doi-asserted-by":"publisher","unstructured":"Allen ER, Krumm SA, Raghwani J, Halldorsson S, Elliott A, Graham VA, Koudriakova E, Harlos K, Wright D, Warimwe GM, Brennan B, Huiskonen JT, Dowall SD, Elliott RM, Pybus OG, Burton DR, Hewson R, Doores KJ, Bowden TA (2018) A protective monoclonal antibody targets a site of vulnerability on the surface of Rift Valley fever virus. Cell Rep 25 (13):3750\u20133758 e3754. https:\/\/doi.org\/10.1016\/j.celrep.2018.12.001","DOI":"10.1016\/j.celrep.2018.12.001"},{"issue":"5","key":"1_CR47","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1159\/000373924","volume":"7","author":"K Terasaki","year":"2015","unstructured":"Terasaki K, Makino S (2015) Interplay between the virus and host in Rift Valley fever pathogenesis. J Innate Immun 7(5):450\u2013458. https:\/\/doi.org\/10.1159\/000373924","journal-title":"J Innate Immun"},{"issue":"3","key":"1_CR48","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.chom.2013.01.012","volume":"13","author":"M Weber","year":"2013","unstructured":"Weber M, Gawanbacht A, Habjan M, Rang A, Borner C, Schmidt AM, Veitinger S, Jacob R, Devignot S, Kochs G, Garcia-Sastre A, Weber F (2013) Incoming RNA virus nucleocapsids containing a 5\u2032-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe 13(3):336\u2013346. https:\/\/doi.org\/10.1016\/j.chom.2013.01.012","journal-title":"Cell Host Microbe"},{"key":"1_CR49","doi-asserted-by":"publisher","unstructured":"Leventhal SS, Wilson D, Feldmann H, Hawman DW (2021) A look into Bunyavirales genomes: functions of non-structural (NS) proteins. Viruses 13(2). https:\/\/doi.org\/10.3390\/v13020314","DOI":"10.3390\/v13020314"},{"issue":"3","key":"1_CR50","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1128\/JVI.75.3.1371-1377.2001","volume":"75","author":"M Bouloy","year":"2001","unstructured":"Bouloy M, Janzen C, Vialat P, Khun H, Pavlovic J, Huerre M, Haller O (2001) Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol 75(3):1371\u20131377. https:\/\/doi.org\/10.1128\/JVI.75.3.1371-1377.2001","journal-title":"J Virol"},{"issue":"3","key":"1_CR51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1099\/0022-1317-34-3-557","volume":"34","author":"R Swanepoel","year":"1977","unstructured":"Swanepoel R, Blackburn NK (1977) Demonstration of nuclear immunofluorescence in Rift Valley fever infected cells. J Gen Virol 34(3):557\u2013561. https:\/\/doi.org\/10.1099\/0022-1317-34-3-557","journal-title":"J Gen Virol"},{"issue":"20","key":"1_CR52","doi-asserted-by":"publisher","first-page":"11333","DOI":"10.1128\/JVI.01549-12","volume":"86","author":"R Benferhat","year":"2012","unstructured":"Benferhat R, Josse T, Albaud B, Gentien D, Mansuroglu Z, Marcato V, Soues S, Le Bonniec B, Bouloy M, Bonnefoy E (2012) Large-scale chromatin immunoprecipitation with promoter sequence microarray analysis of the interaction of the NSs protein of Rift Valley fever virus with regulatory DNA regions of the host genome. J Virol 86(20):11333\u201311344. https:\/\/doi.org\/10.1128\/JVI.01549-12","journal-title":"J Virol"},{"key":"1_CR53","doi-asserted-by":"publisher","unstructured":"Barski M, Brennan B, Miller OK, Potter JA, Vijayakrishnan S, Bhella D, Naismith JH, Elliott RM, Schwarz-Linek U (2017) Rift Valley fever phlebovirus NSs protein core domain structure suggests molecular basis for nuclear filaments. elife 6. https:\/\/doi.org\/10.7554\/eLife.29236","DOI":"10.7554\/eLife.29236"},{"issue":"1","key":"1_CR54","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1038\/s41467-020-17101-y","volume":"11","author":"P Leger","year":"2020","unstructured":"Leger P, Nachman E, Richter K, Tamietti C, Koch J, Burk R, Kummer S, Xin Q, Stanifer M, Bouloy M, Boulant S, Krausslich HG, Montagutelli X, Flamand M, Nussbaum-Krammer C, Lozach PY (2020) NSs amyloid formation is associated with the virulence of Rift Valley fever virus in mice. Nat Commun 11(1):3281. https:\/\/doi.org\/10.1038\/s41467-020-17101-y","journal-title":"Nat Commun"},{"issue":"10","key":"1_CR55","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2217\/fvl-2021-0094","volume":"16","author":"K Peng","year":"2021","unstructured":"Peng K, Lozach PY (2021) Rift Valley fever virus: a new avenue of research on the biological functions of amyloids? Future Virol 16(10):677\u2013689. https:\/\/doi.org\/10.2217\/fvl-2021-0094","journal-title":"Future Virol"},{"issue":"20","key":"1_CR56","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1056\/NEJMp2308666","volume":"389","author":"N Wandera","year":"2023","unstructured":"Wandera N, Olds P, Muhindo R, Ivers L (2023) Rift Valley fever - the need for an integrated response. N Engl J Med 389(20):1829\u20131832. https:\/\/doi.org\/10.1056\/NEJMp2308666","journal-title":"N Engl J Med"},{"issue":"12","key":"1_CR57","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1128\/JCM.39.12.4456-4461.2001","volume":"39","author":"S Garcia","year":"2001","unstructured":"Garcia S, Crance JM, Billecocq A, Peinnequin A, Jouan A, Bouloy M, Garin D (2001) Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds. J Clin Microbiol 39(12):4456\u20134461. https:\/\/doi.org\/10.1128\/JCM.39.12.4456-4461.2001","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1_CR58","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1038\/s41598-023-29023-y","volume":"13","author":"C Park","year":"2023","unstructured":"Park C, Park D, Hassan ZU, Choi SH, Kim S (2023) Comparison of RT-qPCR and RT-ddPCR with rift valley fever virus (RVFV) RNA. Sci Rep 13(1):3085. https:\/\/doi.org\/10.1038\/s41598-023-29023-y","journal-title":"Sci Rep"},{"key":"1_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2023.114693","volume":"315","author":"V Balaraman","year":"2023","unstructured":"Balaraman V, Gaudreault NN, Trujillo JD, Indran SV, Wilson WC, Richt JA (2023) RT-qPCR genotyping assays for differentiating Rift Valley fever phlebovirus strains. J Virol Methods 315:114693. https:\/\/doi.org\/10.1016\/j.jviromet.2023.114693","journal-title":"J Virol Methods"},{"issue":"2","key":"1_CR60","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.virol.2008.05.033","volume":"378","author":"A Billecocq","year":"2008","unstructured":"Billecocq A, Gauliard N, Le May N, Elliott RM, Flick R, Bouloy M (2008) RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses. Virology 378(2):377\u2013384. https:\/\/doi.org\/10.1016\/j.virol.2008.05.033","journal-title":"Virology"},{"issue":"6","key":"1_CR61","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1128\/JVI.80.6.2933-2940.2006","volume":"80","author":"T Ikegami","year":"2006","unstructured":"Ikegami T, Won S, Peters CJ, Makino S (2006) Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol 80(6):2933\u20132940. https:\/\/doi.org\/10.1128\/JVI.80.6.2933-2940.2006","journal-title":"J Virol"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-1-0716-3533-9_7","volume":"2733","author":"B Tercero","year":"2024","unstructured":"Tercero B, Makino S (2024) Reverse genetics system for Rift Valley fever virus. Methods Mol Biol 2733:101\u2013113. https:\/\/doi.org\/10.1007\/978-1-0716-3533-9_7","journal-title":"Methods Mol Biol"},{"issue":"Pt 9","key":"1_CR63","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1099\/vir.0.2008\/002097-0","volume":"89","author":"M Habjan","year":"2008","unstructured":"Habjan M, Penski N, Spiegel M, Weber F (2008) T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus. J Gen Virol 89(Pt 9):2157\u20132166. https:\/\/doi.org\/10.1099\/vir.0.2008\/002097-0","journal-title":"J Gen Virol"},{"issue":"26","key":"1_CR64","doi-asserted-by":"publisher","first-page":"15400","DOI":"10.1073\/pnas.93.26.15400","volume":"93","author":"A Bridgen","year":"1996","unstructured":"Bridgen A, Elliott RM (1996) Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc Natl Acad Sci USA 93(26):15400\u201315404. https:\/\/doi.org\/10.1073\/pnas.93.26.15400","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR65","doi-asserted-by":"publisher","unstructured":"Wichgers Schreur PJ, Bird BH, Ikegami T, Bermudez-Mendez E, Kortekaas J (2023) Perspectives of next-generation live-attenuated Rift Valley fever vaccines for animal and human use. Vaccines (Basel) 11(3). https:\/\/doi.org\/10.3390\/vaccines11030707","DOI":"10.3390\/vaccines11030707"},{"issue":"1","key":"1_CR66","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41541-023-00769-w","volume":"8","author":"C Alkan","year":"2023","unstructured":"Alkan C, Jurado-Cobena E, Ikegami T (2023) Advancements in Rift Valley fever vaccines: a historical overview and prospects for next generation candidates. NPJ Vaccines 8(1):171. https:\/\/doi.org\/10.1038\/s41541-023-00769-w","journal-title":"NPJ Vaccines"}],"container-title":["Methods in Molecular Biology","Rift Valley Fever Virus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3926-9_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T17:02:20Z","timestamp":1721667740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3926-9_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9781071639252","9781071639269"],"references-count":66,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3926-9_1","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"23 July 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}